Ben Parkhurst

Ben Parkhurst joined Flagship Pioneering in 2022 and serves as Senior Director, CMC Lead within the Pioneering Medicines team. In this role, he leads CMC activities for multiple programs, collaborating with Flagship companies and external partners, to accelerate the development of innovative therapeutics. Ben is also driving operational and digital initiatives across the TechOps organization.​

With over 15 years of experience in CMC and drug development, Ben has worked on multiple modalities with a primary focus on Advanced Therapeutic Medicinal Products. Prior to joining Flagship, he was Director of Manufacturing Sciences & Technology at Generation Bio, where he led the development and manufacturing of closed-ended DNA (ceDNA) formulated in LNPs. Earlier in his career, Ben played a key role in establishing uniQure’s GMP facility and the clinical readiness of multiple AAV products. He has also supported projects at Sanofi, Allergan, and Cubist Pharmaceuticals.​

Ben holds a master’s degree in Bioengineering from Tufts University and a bachelor’s degree in Biomedical Engineering from Worcester Polytechnic Institute. He is currently pursuing an MBA at the MIT Sloan School of Management, Class of 2027.